Key statistics
As of last trade Hims & Hers Health Inc (HIMS:NYQ) traded at 29.47, -0.71% below its 52-week high of 29.68, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 29.12 |
---|---|
High | 29.48 |
Low | 27.87 |
Bid | 29.44 |
Offer | 29.48 |
Previous close | 26.69 |
Average volume | 22.88m |
---|---|
Shares outstanding | 218.48m |
Free float | 184.33m |
P/E (TTM) | 61.70 |
Market cap | 5.83bn USD |
EPS (TTM) | 0.4326 USD |
Data delayed at least 15 minutes, as of Nov 13 2024 14:43 GMT.
More ▼
- Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
- Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
- How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
- Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
- Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
- Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
More ▼